Literature DB >> 20830500

Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources.

Hiromu Ito1.   

Abstract

Skeletal injury is one of the most prevalent clinical problems that jeopardize the activities of daily life, especially in our aging society. Mesenchymal stem cells (MSCs) play pivotal roles in regenerating bones after bone injury. MSCs come from the surrounding tissues and/or circulation. Cell sources may be the bone marrow, periosteum, vessel walls, muscle, circulation, and elsewhere, and the migration of MSCs is necessary for bone healing. The mechanism(s) of recruitment and crucial molecules for cell migration are still unclear, but chemokines and their receptors seem to play critical roles. The induction of MSC recruitment from surrounding tissues or from the circulation can be a helpful modality to induce or to support cell-based therapy for bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830500     DOI: 10.1007/s10165-010-0357-8

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  42 in total

1.  Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Samuel Herberg; Sadanand Fulzele; Nianlan Yang; Xingming Shi; Matthew Hess; Sudharsan Periyasamy-Thandavan; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2012-08-21       Impact factor: 3.845

Review 2.  Chemokine Involvement in Fetal and Adult Wound Healing.

Authors:  Swathi Balaji; Carey L Watson; Rajeev Ranjan; Alice King; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

3.  Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles.

Authors:  Kate Fritton; Pei-Gen Ren; Emmanuel Gibon; Allison J Rao; Ting Ma; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-08-14       Impact factor: 3.845

4.  Mesenchymal stem cells with increased stromal cell-derived factor 1 expression enhanced fracture healing.

Authors:  Chih-Yuan Ho; Anita Sanghani; Jia Hua; Melanie Coathup; Priya Kalia; Gordon Blunn
Journal:  Tissue Eng Part A       Date:  2014-11-13       Impact factor: 3.845

Review 5.  Periosteum derived stem cells for regenerative medicine proposals: Boosting current knowledge.

Authors:  Concetta Ferretti; Monica Mattioli-Belmonte
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 6.  Tissue Engineering in Orthopaedics.

Authors:  Alexander M Tatara; Antonios G Mikos
Journal:  J Bone Joint Surg Am       Date:  2016-07-06       Impact factor: 5.284

7.  Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation.

Authors:  Joel K Wise; Dale Rick Sumner; Amarjit S Virdi
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

Review 8.  Clinical considerations of regenerative medicine in osteoporosis.

Authors:  Hiromu Ito
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

9.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

10.  Hyperlipidemia compromises homing efficiency of systemically transplanted BMSCs and inhibits bone regeneration.

Authors:  Quan-Chen Xu; Peng-Jie Hao; Xin-Bo Yu; Shu-Lan Chen; Mei-Jiao Yu; Jin Zhang; Pi-Shan Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.